Episode 6 - The Future of Neurodevelopmental Therapeutics with Fiona Nielsen
Update: 2024-04-15
Description
The market for epilepsy treatment is worth $18 billion, yet today's anti-epilepsy drugs are ineffective for nearly 40% of patients. With new fields of scientific research, addressing this gap could change the lives of millions.
We sat down with Fiona Nielsen, CEO of Neurolentech, to discuss their groundbreaking work identifying novel drug treatments for people living with autism, epilepsy, and intellectual disability.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
